SUBSCRIBE
SUBSCRIBE

IgA nephropathy

Entrance to Vertex's office in Boston, Massachusetts
Deals
Vertex Buys Alpine for $4.9B to Bolster Autoimmune and Inflammatory Disease Pipeline
Vertex Pharmaceuticals on Wednesday announced it is acquiring clinical-stage immunotherapy company Alpine Immune Sciences for $4.9 billion in cash, the largest acquisition so far this year.
April 11, 2024
 · 
2 min read
 · 
Tristan Manalac
Load More
PRESS RELEASES
Press Releases
Climb Bio Expands Pipeline Through an Exclusive License to Develop and Commercialize an Antibody Targeting the APRIL Pathway for IgA Nephropathy
January 10, 2025
 · 
6 min read
Press Releases
Otsuka Provides Update on Sibeprenlimab, an Investigational Monoclonal Antibody for the Treatment of IgA Nephropathy in Adults
November 20, 2024
 · 
6 min read
Press Releases
BioCity presents late-breaking clinical trial results with SC0062 for IgA Nephropathy at ASN Kidney Week 2024 as published in the Journal of the American Society of Nephrology
November 5, 2024
 · 
6 min read
Press Releases
Travere Therapeutics Presents Data Reinforcing Clinical Benefit of FILSPARI® (Sparsentan) in IgAN and Late-Breaking Presentation in FSGS at ASN Kidney Week 2024
October 28, 2024
 · 
16 min read
Press Releases
Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024
October 28, 2024
 · 
7 min read
Press Releases
Biogen Announces Late Breaker and New Data Presentations at American Society of Nephrology (ASN) Kidney Week 2024
October 23, 2024
 · 
5 min read
Press Releases
Travere Therapeutics and CSL Vifor Announce Swissmedic Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy
October 17, 2024
 · 
14 min read
Press Releases
CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
October 17, 2024
 · 
4 min read
Press Releases
Travere Therapeutics to Present Abstracts at American Society of Nephrology (ASN) Kidney Week 2024
October 15, 2024
 · 
17 min read
Press Releases
Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases
October 10, 2024
 · 
6 min read
Press Releases
Vera Therapeutics Announces Expanded Atacicept Development Program In Multiple Autoimmune Kidney Diseases
October 2, 2024
 · 
7 min read
Press Releases
Breakthrough Therapy Designation (BTD) for BioCity’s SC0062, a selective endothelin type A (ETA) antagonist, granted by National Medical Products Administration for IgA nephropathy (IgAN) with proteinuria
September 26, 2024
 · 
4 min read
Load More